Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm in Nebraska
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Nebraska
| Provider | Medicare | Services |
|---|---|---|
| Behrens, Brent P.A.-C | $84.50 | 170 |
| Papenfuss, Jason M.D. | $102.46 | 152 |
| Basler, Geoffrey M.D. | $82.26 | 141 |
| Behrens, Brent P.A.-C | $55.48 | 68 |
| Darling, Melissa MD | $103.60 | 68 |
| Stolmeier, Deirdre M.D. | $102.84 | 62 |
| Largen, Rex MD | $111.83 | 52 |
Nebraska Pricing in Context
In Nebraska, CPT code 17281 (Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm) carries an average Medicare payment of $94.10 — 17% below the national benchmark of $112.86. 68 providers across the state submitted claims for this procedure in 2023, performing 1.2K total services. Individual payments in NE ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Nebraska is $363.89, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Nebraska sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in Nebraska lands near $258.50, with self-pay cash prices typically around $194.65. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm cost in Nebraska?
The average Medicare payment for Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm in Nebraska is $94.10, which is 17% below the national average of $112.86. Providers in NE typically bill $363.89 for this procedure.
What does Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm cost with insurance in Nebraska?
With commercial insurance in Nebraska, Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm costs an estimated $258.50. Without insurance, the estimated cash price is $194.65. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm in Nebraska?
68 providers in Nebraska billed Medicare for Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm in 2023, performing 1.2K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm cheaper in Nebraska than the national average?
Yes — Destruction Of Cancer Skin Growth Of Face, Ears, Eyelids, Nose, Lips, Or Mouth, 0.6-1.0 Cm costs 17% below the national average in Nebraska. The state average Medicare payment is $94.10 compared to $112.86 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.